The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

MMI270     (2R)-N-hydroxy-2-[(4- methoxyphenyl)sulfony...

Synonyms: CHEMBL267178, CGS-27023A, AC1L9JQY, DNC000955, DNC010718, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CGS

  • The broad-spectrum MMP inhibitor CGS 27023A was tested to determine its potential as a therapy for atherosclerosis, aneurysm, and restenosis [1].
  • Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits [2].
  • Treatment with CGS 27023A (p.o., b.i.d. at 50 mg/kg) had no effect on the extent of aortic atherosclerosis (36 +/- 4% versus 30 +/- 2% in controls), but both aortic medial elastin destruction and ectasia grade were significantly reduced (38% and 36%, respectively, p < 0.05) [1].
 

Psychiatry related information on CGS

 

High impact information on CGS

 

Biological context of CGS

 

Anatomical context of CGS

 

Associations of CGS with other chemical compounds

 

Gene context of CGS

  • Among the synthesized compounds, the ethoxyethoxy derivative 3o and the methoxypropoxy derivative 3p exhibited much more potent HB-EGF shedding inhibitory activity than CGS 27023A [11].

References

  1. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Prescott, M.F., Sawyer, W.K., Von Linden-Reed, J., Jeune, M., Chou, M., Caplan, S.L., Jeng, A.Y. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  2. Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits. O'Byrne, E.M., Parker, D.T., Roberts, E.D., Goldberg, R.L., MacPherson, L.J., Blancuzzi, V., Wilson, D., Singh, H.N., Ludewig, R., Ganu, V.S. Inflamm. Res. (1995) [Pubmed]
  3. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo. Kopka, K., Breyholz, H.J., Wagner, S., Law, M.P., Riemann, B., Schröer, S., Trub, M., Guilbert, B., Levkau, B., Schober, O., Schäfers, M. Nucl. Med. Biol. (2004) [Pubmed]
  4. Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. DiMicco, M.A., Patwari, P., Siparsky, P.N., Kumar, S., Pratta, M.A., Lark, M.W., Kim, Y.J., Grodzinsky, A.J. Arthritis Rheum. (2004) [Pubmed]
  5. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Ganu, V., Goldberg, R., Peppard, J., Rediske, J., Melton, R., Hu, S.I., Wang, W., Duvander, C., Heinegård, D. Arthritis Rheum. (1998) [Pubmed]
  6. Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor. Eskens, F.A., Levitt, N.C., Sparreboom, A., Choi, L., Mather, R., Verweij, J., Harris, A.L. Clin. Cancer Res. (2000) [Pubmed]
  7. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development. Lee, P.P., Hwang, J.J., Mead, L., Ip, M.M. J. Cell. Physiol. (2001) [Pubmed]
  8. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Lee, P.P., Hwang, J.J., Murphy, G., Ip, M.M. Endocrinology (2000) [Pubmed]
  9. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Moy, F.J., Chanda, P.K., Chen, J.M., Cosmi, S., Edris, W., Skotnicki, J.S., Wilhelm, J., Powers, R. Biochemistry (1999) [Pubmed]
  10. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha. Ganu, V., Melton, R., Wang, W., Roberts, D. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  11. Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitors. Yoshiizumi, K., Yamamoto, M., Miyasaka, T., Ito, Y., Kumihara, H., Sawa, M., Kiyoi, T., Yamamoto, T., Nakajima, F., Hirayama, R., Kondo, H., Ishibushi, E., Ohmoto, H., Inoue, Y., Yoshino, K. Bioorg. Med. Chem. (2003) [Pubmed]
 
WikiGenes - Universities